Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
Lupin Ltd
-(LUPIN)
XNSE:LUPIN, XBOM:LUPIN
Lupin Ltd Q4FY24; 52% rise in Profits
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
Lupin Ltd Q1FY24; 29% rise in Revenue
Lupin is engaged in the business of Manufacture of Pharmaceuticals. Financial Results: Lupin Ltd reported Revenues for Q1FY24 of ₹4,814.00 Crores up
Lupin Ltd (LUPIN) Q4 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Lupin Limited Q4FY23 Earnings Story
Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin
Earnings Summary Of Lupin Limited For Q3 FY23
Lupin Limited is a pharmaceutical company headquartered in Mumbai, India. The company was founded in 1968 and has operations in over 100
Lupin Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing its US
Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Lupin Limited Q3FY23; 47% Growth in Profits
Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs in Q3FY23
Lupin Q2FY23 results out: Net profit rises more than 100%
Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the
Lupin Ltd (LUPIN) Q2 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan --
Lupin Ltd (LUPIN) Q1 FY23 Earnings Concall Transcript
Lupin Ltd (NSE: LUPIN) Q1 FY23 Earnings Concall dated Aug. 04, 2022 Corporate Participants: Kamal Kishore Sharma -- Vice Chairman of the
Lupin Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall Q&A Highlights: Pritesh Vora - Mission Street India - Analyst
Lupin Ltd. (LUPIN) Q4 FY22 Earnings Concall Transcript
Lupin Ltd. (NSE: LUPIN) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Ramesh Swaminathan -- Executive Director, Global CFO and Head Nilesh